Cytiva, now with the life sciences business from Pall Corporation, is a global biotechnology leader dedicated to helping customers discover and commercialize the next generation of therapeutics. We bring dedicated technical expertise and a broad portfolio of tools, technologies, and services that enable the development, manufacture, and delivery of transformative medicines to patients. We're the provider of leading life science brands such as ÄKTA, Amersham, HyClone, MabSelect and Whatman. We are part of Danaher, a global science and technology leader. Along with other Danaher businesses, we accelerate the impact of tomorrow’s science and technology innovation to improve human health. Visit https://www.cytiva.com/privacy to review our privacy policy.
我们正在追踪 Cytiva 的市场扩张
最近 90 天内有 132 个信号。
Cytiva 的国际扩张与竞争对手的对比情况
Cytiva你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Cytiva你 | 0 | 0 | — | 0 | 0 |
Service Sales Development Manager EMEA West (m/f/d)
查看职位Strasbourg, Grand Est, France · 前天
Service Sales Development Manager EMEA West (m/f/d)
查看职位Marseille, Provence-Alpes-Côte d'Azur, France · 前天
Service Sales Development Manager EMEA West (m/f/d)
查看职位Bordeaux, Nouvelle-Aquitaine, France · 前天
Meet Lars
进行中
Streamline your microbiology QC to cut rework, reduce paperwork, and move your release decisions faster
进行中
Accelerate product release with robust microbiology testing solutions
进行中外国制药设备制造商开始拒绝向俄罗斯供应零件。德国公司Syntegon和GEA已暂停供应。其他公司如Sartorius和Cytiva已暂停接受订单，但承诺会重返俄罗斯市场。
全球细胞培养市场预计将从2022年的209.6亿美元增长到2030年的561.9亿美元，这一增长由医学和生物技术领域的研发增加所推动。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Cytiva 的业务、市场和增长信号的快速解答。
